Thalassemia News and Research

Latest Thalassemia News and Research

Acetylon Pharmaceuticals presents positive interim data from two ricolinostat clinical trials at ASH 2013

Acetylon Pharmaceuticals presents positive interim data from two ricolinostat clinical trials at ASH 2013

Genetically engineered cell therapies demonstrate early efficacy, safety in patients with blood disorders

Genetically engineered cell therapies demonstrate early efficacy, safety in patients with blood disorders

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

CHEO-led study confirms validity, reliability of quality of life measurement tool for thalassemia major

CHEO-led study confirms validity, reliability of quality of life measurement tool for thalassemia major

IVF and chromosome testing: an interview with Dr. Santiago Munné

IVF and chromosome testing: an interview with Dr. Santiago Munné

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Alnylam advances Development Candidate for ALN-AS1 for treatment of hepatic porphyrias

Scientists uncover new approach to develop induced pluripotent stem cells for in vivo disease modeling

Scientists uncover new approach to develop induced pluripotent stem cells for in vivo disease modeling

Study: Ciclopirox drug completely eradicates infectious HIV from cell cultures

Study: Ciclopirox drug completely eradicates infectious HIV from cell cultures

Global Industry Analysis Report on Companion Diagnostics Market

Global Industry Analysis Report on Companion Diagnostics Market

Sangamo BioSciences signs definitive agreement to buy Ceregene

Sangamo BioSciences signs definitive agreement to buy Ceregene

FDA grants Orphan Drug Designation to Alnylam ALN-AT3 for treatment of hemophilia B

FDA grants Orphan Drug Designation to Alnylam ALN-AT3 for treatment of hemophilia B

Alnylam releases positive top-line data from ALN-TTRsc Phase I trial for TTR-mediated amyloidosis

Alnylam releases positive top-line data from ALN-TTRsc Phase I trial for TTR-mediated amyloidosis

Alnylam Pharmaceuticals presents new pre-clinical data of ALN-AT3 at ISTH meeting

Alnylam Pharmaceuticals presents new pre-clinical data of ALN-AT3 at ISTH meeting

Alnylam presents new pre-clinical data of ALN-CC5 for treatment of complement-mediated diseases

Alnylam presents new pre-clinical data of ALN-CC5 for treatment of complement-mediated diseases

Cerus enrolls patient in two European clinical trials for INTERCEPT System for RBCs

Cerus enrolls patient in two European clinical trials for INTERCEPT System for RBCs

Alnylam reports pre-clinical data from ALN-AS1 program for treatment of AIP

Alnylam reports pre-clinical data from ALN-AS1 program for treatment of AIP

New partnership to introduce advanced genetic testing technologies to Turkey

New partnership to introduce advanced genetic testing technologies to Turkey

Two studies shed light on molecular biology of three blood disorders

Two studies shed light on molecular biology of three blood disorders

Acceleron commences ACE-536 phase 2 study in beta-thalassemia

Acceleron commences ACE-536 phase 2 study in beta-thalassemia

Gamida Cell announces results from NiCord Phase I/II study on hematological malignancies

Gamida Cell announces results from NiCord Phase I/II study on hematological malignancies